LDN-193189 (hydrochloride)
目录号 : KCM11414
CAS No. : 1435934-00-1
纯度 : ≥98%
LDN-193189 inhibits SMAD1/5/8 phosphorylation by the bone morphogenetic protein (BMP) type I receptors, which are known as activin receptor-like kinases (ALKs), with an IC value of 4.9 nM. In in vitro kinase assays, it shows specificity for ALK1, 2, 3, and 6 (ICs = 0.8, 0.8, 5.3, and 16.7 nM, respectively) over ALK4 and 5 (ICs = 101 and 350 nM, respectively). LDN-193189 has been used to inhibit BMP type I receptor activity to study the pathogenesis of fibrodysplasia ossificans progressive, a congenital hyperossification disorder, and to examine the role of osteogenesis in prostate tumor metastases in bone.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
分子式 |
C25H22N6.2HCl
|
分子量 |
406.48262
|
CAS号 |
1435934-00-1
|
中文名称 |
LDN 193189 hydrochloride
|
储存方式 |
-20°C
|